Biblio

Export 238 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Keyword is G  [Clear All Filters]
2016
S. Lim, Choi, J. Gyu, Moon, M., Kim, H. Geun, Lee, W., Bak, H. - R., Sung, H., Park, C. Hye, Kim, S. Yeou, and Oh, M. Sook, “An Optimized Combination of Ginger and Peony Root Effectively Inhibits Amyloid-β Accumulation and Amyloid-β-Mediated Pathology in AβPP/PS1 Double-Transgenic Mice.”, J Alzheimers Dis, vol. 50, no. 1, pp. 189-200, 2016.
P. Banerjee, Sahoo, A., Anand, S., Bir, A., and Chakrabarti, S., “The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 3, pp. 681-93, 2016.
Y. Manso, Comes, G., López-Ramos, J. C., Belfiore, M., Molinero, A., Giralt, M., Carrasco, J., Adlard, P. A., Bush, A. I., Delgado-García, J. María, and Hidalgo, J., “Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 81-95, 2016.
N. Voyle, Keohane, A., Newhouse, S., Lunnon, K., Johnston, C., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., Hodges, A., Kiddle, S., and Dobson, R. Jb, “A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.”, J Alzheimers Dis, vol. 49, no. 3, pp. 659-69, 2016.
N. Voyle, Keohane, A., Newhouse, S., Lunnon, K., Johnston, C., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., Hodges, A., Kiddle, S., and Dobson, R. Jb, “A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.”, J Alzheimers Dis, vol. 49, no. 3, pp. 659-69, 2016.
B. Yoon, Shim, Y. S., Park, H. - K., Park, S. Ah, Choi, S. Hye, and Yang, D. Won, “Predictive factors for disease progression in patients with early-onset Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 85-91, 2016.
B. N. Dugger, Whiteside, C. M., Maarouf, C. L., Walker, D. G., Beach, T. G., Sue, L. I., Garcia, A., Dunckley, T., Meechoovet, B., Reiman, E. M., and Roher, A. E., “The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 345-56, 2016.
A. K. Tripathi and Singh, N., “Prion Protein-Hemin Interaction Upregulates Hemoglobin Synthesis: Implications for Cerebral Hemorrhage and Sporadic Creutzfeldt-Jakob Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 107-21, 2016.
E. Oldoni, Fumagalli, G. G., Serpente, M., Fenoglio, C., Scarioni, M., Arighi, A., Bruno, G., Talarico, G., Confaloni, A., Piscopo, P., Nacmias, B., Sorbi, S., Rainero, I., Rubino, E., Pinessi, L., Binetti, G., Ghidoni, R., Benussi, L., Grande, G., Arosio, B., Bursey, D., Kauwe, J. S., Cioffi, S. Mg, Arcaro, M., Mari, D., Mariani, C., Scarpini, E., and Galimberti, D., “PRNP P39L Variant is a Rare Cause of Frontotemporal Dementia in Italian Population.”, J Alzheimers Dis, vol. 50, no. 2, pp. 353-7, 2016.
X. - P. Hong, Chen, T., Yin, N. - N., Han, Y. - M., Yuan, F., Duan, Y. - J., Shen, F., Zhang, Y. - H., and Bin Chen, Z. -, “Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain.”, J Alzheimers Dis, vol. 51, no. 2, pp. 605-17, 2016.
X. - P. Hong, Chen, T., Yin, N. - N., Han, Y. - M., Yuan, F., Duan, Y. - J., Shen, F., Zhang, Y. - H., and Bin Chen, Z. -, “Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain.”, J Alzheimers Dis, vol. 51, no. 2, pp. 605-17, 2016.
S. Baiardi, Capellari, S., Ladogana, A., Strumia, S., Santangelo, M., Pocchiari, M., and Parchi, P., “Revisiting the Heidenhain Variant of Creutzfeldt-Jakob Disease: Evidence for Prion Type Variability Influencing Clinical Course and Laboratory Findings.”, J Alzheimers Dis, vol. 50, no. 2, pp. 465-76, 2016.
B. E. Gavett, John, S. E., Gurnani, A. S., Bussell, C. A., and Saurman, J. L., “The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 2, pp. 531-45, 2016.
J. Bennett, Burns, J., Welch, P., and Bothwell, R., “Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1179-87, 2016.
A. Palmeri, Mammana, L., Tropea, M. Rosaria, Gulisano, W., and Puzzo, D., “Salidroside, a Bioactive Compound of Rhodiola Rosea, Ameliorates Memory and Emotional Behavior in Adult Mice.”, J Alzheimers Dis, vol. 52, no. 1, pp. 65-75, 2016.
L. Gao, Cui, Z., Shen, L., and Ji, H. - F., “Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis.”, J Alzheimers Dis, vol. 50, no. 1, pp. 13-7, 2016.
L. Gao, Cui, Z., Shen, L., and Ji, H. - F., “Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis.”, J Alzheimers Dis, vol. 50, no. 1, pp. 13-7, 2016.
Q. Ye, Bai, F., and Zhang, Z., “Shared Genetic Risk Factors for Late-Life Depression and Alzheimer's Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 1-15, 2016.
J. - P. Morin, Cerón-Solano, G., Velázquez-Campos, G., Pacheco-López, G., Bermúdez-Rattoni, F., and Díaz-Cintra, S., “Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 69-79, 2016.
M. A. Fernández-Blázquez, Ávila-Villanueva, M., Maestú, F., and Medina, M., “Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 52, no. 1, pp. 271-81, 2016.
N. E. Gray, Zweig, J. A., Kawamoto, C., Quinn, J. F., and Copenhaver, P. F., “STX, a Novel Membrane Estrogen Receptor Ligand, Protects Against Amyloid-β Toxicity.”, J Alzheimers Dis, vol. 51, no. 2, pp. 391-403, 2016.
M. D. Zwan, Villemagne, V. L., Doré, V., Buckley, R., Bourgeat, P., Veljanoski, R., Salvado, O., Williams, R., Margison, L., Rembach, A., S Macaulay, L., Martins, R., Ames, D., van der Flier, W. M., Ellis, K. A., Scheltens, P., Masters, C. L., and Rowe, C. C., “Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden.”, J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
M. Tong, Deochand, C., Didsbury, J., and de la Monte, S. M., “T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
M. Tong, Deochand, C., Didsbury, J., and de la Monte, S. M., “T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 123-38, 2016.
R. Yu, Deochand, C., Krotow, A., Leão, R., Tong, M., Agarwal, A. R., Cadenas, E., and de la Monte, S. M., “Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.”, J Alzheimers Dis, vol. 50, no. 1, pp. 133-48, 2016.

Pages